Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCR/ABL transcripts and leukemia phenotype: an unsolved puzzle

G Saglio1, F Pane, G Martinelli

  • 1Dipartimento di Scienze Biomediche e Oncologia Umana dell'Università di Torino, Ospedale S. Luigi Gonzaga, Orbassano-Torino, Italy.

Leukemia & Lymphoma
|July 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort study.

Annals of hematology·2026
Same author

Long-acting lipegfilgrastim and antimicrobials as vigorous primary prophylaxis in bendamustine-treated patients with indolent B cell non-Hodgkin lymphoma: a multicentric real-life experience.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study.

British journal of haematology·2025
Same author

Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study.

Hematological oncology·2024
Same author

Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.

Hematological oncology·2023
Same author

Long-term Cryopreserved Autologous Hematopoietic Stem Cells Following Azacytidine to Successfully Treat Severe Invasive Pulmonary Aspergillosis After Therapy-Related Myelodysplastic Syndrome and CD8<sup>+</sup> T-cell Autoimmune Disorders: A Case Report.

Clinical lymphoma, myeloma & leukemia·2021
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same journal

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

Leukemia & lymphoma·2026
See all related articles

The Philadelphia chromosome (Ph) is a common genetic abnormality in blood cancers. Its presence, linked to BCR/ABL gene rearrangements, may influence leukemia type through variations in protein expression and levels.

Area of Science:

  • Hematology
  • Cytogenetics
  • Molecular Biology

Background:

  • The Philadelphia chromosome, resulting from the t(9;22) translocation, is a frequent cytogenetic abnormality in hematological malignancies.
  • Unlike other translocations, Ph is associated with various leukemia types, including chronic myelogenous leukemia and acute lymphoblastic leukemia, especially in older adults.

Purpose of the Study:

  • To explore the pathogenetic relationship between the Philadelphia chromosome and different leukemia phenotypes.
  • To investigate the role of qualitative and quantitative variations in BCR/ABL protein expression in determining leukemia phenotype.

Main Methods:

  • Cytogenetic analysis to identify the t(9;22) translocation.
  • Molecular techniques to characterize BCR/ABL gene rearrangements.

Related Experiment Videos

  • Analysis of BCR/ABL protein expression levels and types in leukemia cells.

    • Main Results:

    • The Philadelphia chromosome is consistently associated with BCR/ABL gene rearrangements, but with molecular variability.
    • Observations suggest that both the type and quantity of BCR/ABL proteins may influence the resulting leukemia phenotype.

    Conclusions:

    • The Philadelphia chromosome's association with diverse leukemia phenotypes is complex.
    • Qualitative and quantitative differences in BCR/ABL proteins are implicated in determining leukemia characteristics.